Temozolomide and capecitabine are chemotherapy drugs used to treat various types of cancer. Temozolomide works by alkylating DNA in tumor cells, damaging the DNA and killing the cells. It is commonly used to treat astrocytoma and glioblastoma multiforme. Capecitabine works by reducing thymidine and uridine triphosphate levels, inhibiting DNA and RNA/protein synthesis in tumor cells. It is used to treat breast and colorectal cancers. Both drugs can cause side effects like fatigue, nausea, vomiting, diarrhea, and myelosuppression.
Temozolomide and capecitabine are chemotherapy drugs used to treat various types of cancer. Temozolomide works by alkylating DNA in tumor cells, damaging the DNA and killing the cells. It is commonly used to treat astrocytoma and glioblastoma multiforme. Capecitabine works by reducing thymidine and uridine triphosphate levels, inhibiting DNA and RNA/protein synthesis in tumor cells. It is used to treat breast and colorectal cancers. Both drugs can cause side effects like fatigue, nausea, vomiting, diarrhea, and myelosuppression.
Temozolomide and capecitabine are chemotherapy drugs used to treat various types of cancer. Temozolomide works by alkylating DNA in tumor cells, damaging the DNA and killing the cells. It is commonly used to treat astrocytoma and glioblastoma multiforme. Capecitabine works by reducing thymidine and uridine triphosphate levels, inhibiting DNA and RNA/protein synthesis in tumor cells. It is used to treat breast and colorectal cancers. Both drugs can cause side effects like fatigue, nausea, vomiting, diarrhea, and myelosuppression.
Temozolomide The therapeutic Contraindications Astrocytoma Fatigue
benefit of Hypersensitivity to Adult: PO 150 mg/m2 q.d. Nausea and vo
Brand Name: temozolomide temozolomide, DTIC, or times 5 consecutive d per Constipation temozolomide depends on its ability dacarbazine; pregnancy 28 d treatment cycle; Loss of appetit to alkylate/methylate (category D), lactation. subsequent doses are Amenorrhoea DNA, which most based on absolute Infection often occurs at the N- neutrophil count on day 21 7 or O-6 positions of or at least 48 h before next guanine residues. scheduled cycle (see This methylation prescribing information for damages the DNA dosage adjustments based and triggers the death on neutrophil count) of tumor cells. Glioblastoma Multiforme Adult: PO 75 mg/m2 q.d. for 42 d with focal radiotherapy; after 4 wk, maintenance phase of 150 mg/m2 ANTI-METABOLITES Capecitabine FdUMP inhibits DNA Contraindications Breast Cancer, Colorectal Anemia, back pain synthesis by reducing Hypersensitivity to Cancer bloody, black, or tarry Brand Name: Xeloda normal thymidine capecitabine, doxifluridine, Adult: PO 2500 mg/m2/d in body aches, chest pa production, while 5-FU; myelosuppression; 2 divided doses times 2 Chills, constipation FUTP inhibits RNA dihydropyrimidine wk, then 1 wk off. Repeat coughing up blood and protein synthesis dehydrogenase (DPD) decreased appetite by competing with deficiency; females of Renal Impairment decreased low blood uridine triphosphate. 1 childbearing age; active Clcr 30–50 mL/min reduce decreased white bloo The active moiety of infection; jaundice; severe dose by 25%, <30 mL/min capecitabine, renal failure or impairment; do not use dehydration fluorouracil, is cell pregnancy (category D); difficult or labored b cycle phase-specific lactation, children <18 y. mouth (S- phase). easy bruising or bleed eye irritation, fever flu symptoms hair loss, headache inflamed and sore mo lightheadedness loss of appetite mild skin rash nausea numbness or tingling or feet pain, tenderness, redn blistering, or peeling or feet pale skin rapid heart rate severe diarrhea shortness of breath stomach pain or upse swelling, rapid weight taste disturbance tired feeling trouble concentrating vomit that looks like c Vomiting, weakness white patches or sor mouth or lips yellowing of the s (jaundice)